Skip to main content
OpenTrials

Clinical trial condition

Granulomatosis with Polyangiitis

Explore clinical trials studying Granulomatosis with Polyangiitis. Study availability and eligibility vary by location and protocol.

75 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Granulomatosis with Polyangiitis trial results

Completed

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Belimumab in Remission of VASculitis

NCT01663623

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +17 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Covina, California, United States
View all 89 locations
View Trial Details
Completed

The ANCA Vasculitis Questionnaire (AAV-PRO©)

NCT02507024

Conditions
ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +28 more
Locations
  • University of South Florida Tampa, Florida, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

NCT00104299

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Boston University Boston, Massachusetts, United States
  • Mayo Clinic Foundation Rochester, Minnesota, United States
View Trial Details
Completed

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

NCT00530075

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations
  • General Faculty Hospital Prague, Czechia
  • Reumatologisk Klinik Copenhagen, Denmark
  • Universitatsklinikum Schleswig-Holstein Lübeck, Germany
  • University Hospital Maastricht Maastricht, Netherlands
View Trial Details
Completed

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

NCT00468208

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations
  • The Johns Hopkins Vasculitis Center Baltimore, Maryland, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Mayo Clinic College of Medicine Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions